Bio Financial Statements From 2010 to 2026
| BENH Stock | USD 0 0.00 0.00% |
Check Bio En financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio En's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bio financial statements analysis is a perfect complement when working with Bio En Valuation or Volatility modules.
Bio |
Bio En Holdings Corp Company Shares Owned By Insiders Analysis
Bio En's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Bio En Shares Owned By Insiders | 59.91 % |
Most of Bio En's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio En Holdings Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 59% of Bio En Holdings Corp are shares owned by insiders. This is much higher than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Bio En Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio En's current stock value. Our valuation model uses many indicators to compare Bio En value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio En competition to find correlations between indicators driving Bio En's intrinsic value. More Info.Bio En Holdings Corp is number one stock in return on asset category among its peers. It also is the top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bio En by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bio En's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Bio En Financial Statements
Investors use fundamental indicators, such as Bio En's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio En's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Previously, it was focused on building, operating, and maintaining a bio-mass to energy facility on the Island of Malta. The company was founded in 2014 and is headquartered in Secaucus, New Jersey. Bio-En Holdings is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Bio Pink Sheet
Bio En financial ratios help investors to determine whether Bio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio En security.